Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials - Concepedia

Concepedia

Publication | Closed Access

Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials

150

Citations

17

References

2005

Year

Mark Nelson, Keikawus Arastéh, Bonaventura Clotet, David A. Cooper, Keith Henry, Christine Katlama, Jacob Lalezari, Adriano Lazzarin, Julio Montaner, Mary O’Hearn,

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

These data demonstrate durable efficacy of enfuvirtide plus OB over 48 weeks.

References

	Year	Citations

Page 1